Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 Study von Saadoun, D, Pol, S, Ferfar, Y, Hezode, C, Ahmed, S.N.S, Alric, L, de Saint Martin, L, Bouyer, A.S, Musset, L, Poynard, T, Rigon, M.R, Cacoub, P

Volltext

PS-099 - Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 Study von Saadoun, D., Pol, S., Ferfar, Y., Hezode, C., Ahmed, S.N.S., Alric, L., de Saint Martin, L., Bouyer, A.S., Musset, L., Poynard, T., Rigon, M.R., Cacoub, P.

Volltext

Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants von Asselah, T., Pol, S., Hezode, C., Loustaud-Ratti, V., Leroy, V., Ahmed, S.N.S., Ozenne, V., Bronowicki, J.-P., Larrey, D., Tran, A., Alric, L., Nguyen-Khac, E., Robertson, M., Hanna, G., Brown, D., Asante-Appiah, E., Ludmerer, S., Su, M., Hwang, P., Klopfer, S., Dutko, F., Guidoum, A., Hagen, K., Haber, B., Talwani, R., Serfaty, L.

Volltext

GS-006 - Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants von Asselah, T., Pol, S., Hezode, C., Loustaud-Ratti, V., Leroy, V., Ahmed, S.N.S., Ozenne, V., Bronowicki, J.-P., Larrey, D., Tran, A., Alric, L., Nguyen-Khac, E., Robertson, M., Hanna, G., Brown, D., Asante-Appiah, E., Ludmerer, S., Su, M., Hwang, P., Klopfer, S., Dutko, F., Guidoum, A., Hagen, K., Haber, B., Talwani, R., Serfaty, L.

Volltext

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplante... von Bizollon, T, Ahmed, S N S, Radenne, S, Chevallier, M, Chevallier, P, Parvaz, P, Guichard, S, Ducerf, C, Baulieux, J, Zoulim, F, Trepo, C

Volltext